abstract |
The invention provides novel bis-pyridylpyridones that are antagonists in the melanin concentrating hormone receptor 1 (MCHR1), farmmacetic compositions containing them, methods for their preparation, and their use in therapy and for the treatment of obesity and / or diabetes. |